Feasibility and safety of 30-minute Trastuzumab reloading infusion in patients with HER2-positive solid tumors

Shemroy McCarthy, Mohammad Harris Jalili, Sara S Kim

Open source

DOI
10.1177/10781552261491928
Published
2026-09-25
Container
Journal of Oncology Pharmacy Practice
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10781552261491928,
  title = {Feasibility and safety of 30-minute Trastuzumab reloading infusion in patients with HER2-positive solid tumors},
  author = {Shemroy McCarthy and Mohammad Harris Jalili and Sara S Kim},
  year = {2026},
  journal = {Journal of Oncology Pharmacy Practice},
  doi = {10.1177/10781552261491928},
  url = {https://doi.org/10.1177/10781552261491928}
}

RIS

TY  - JOUR
TI  - Feasibility and safety of 30-minute Trastuzumab reloading infusion in patients with HER2-positive solid tumors
AU  - Shemroy McCarthy
AU  - Mohammad Harris Jalili
AU  - Sara S Kim
PY  - 2026
JO  - Journal of Oncology Pharmacy Practice
DO  - 10.1177/10781552261491928
UR  - https://doi.org/10.1177/10781552261491928
ER  - 

APA

McCarthy, S., Jalili, M. H., & Kim, S. S. (2026). Feasibility and safety of 30-minute Trastuzumab reloading infusion in patients with HER2-positive solid tumors. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261491928

Source records